The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases.

By P. Hassa, M. Hottiger. Frontiers in Bioscience, 2008

604 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets (2010, neutral): “The modification most likely occurs on glutamate, aspartate, or lysine residues, although historically the evidence for covalent modification of specific residues has been weak (D’Amours et al., 1999; Hassa and Hottiger, 2008).”
Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib (2013, background): “Mol Cancer Ther; 13(2) February 2014 Molecular Cancer Therapeutics 434”
Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats (2011, background): “Moreover, NADH is also able to promote the formation of H2O2 in the presence of iron [78].”
PARP inhibition: PARP1 and beyond (2010, background): “The amino-terminal DNA-binding domain contains two zinc fingers that are important for the binding of PARP1 to single-strand breaks and double-strand breaks (DSBs”